2,4,6-trihydroxyacetophenone and Parkinson Disease, Secondary

2,4,6-trihydroxyacetophenone has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, XQ; Cao, SN; Hu, JP; Li, Y; Wang, XL; Wang, YD; Xu, S; Yu, SS; Yu, WW; Zhang, D	1

Other Studies

1 other study(ies) available for 2,4,6-trihydroxyacetophenone and Parkinson Disease, Secondary

Article	Year
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway. Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Discovery; Male; Mice, Inbred ICR; Mice, Transgenic; Neuroprotective Agents; Parkinson Disease, Secondary; Phloroglucinol; Serine; Signal Transduction; src-Family Kinases	2016

Article

Year

A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.

Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Discovery; Male; Mice, Inbred ICR; Mice, Transgenic; Neuroprotective Agents; Parkinson Disease, Secondary; Phloroglucinol; Serine; Signal Transduction; src-Family Kinases

2016